Foot complications in diabetes can be decreased by preventive measures. The authors evaluated the current diabetic foot screening and prevention programme of the diabetes outpatient clinic of their university hospital, by assessing the presence of risk factors for the development of foot disorders and the preventive measures taken.
Introduction
Foot complications have an enormous impact on the quality of life of patients with diabetes mellitus and the financial cost is considerable (Bakker and Dooren, 1994; Ollendorf et al, 1998) . Frequent assessment of risk factors (neuropathy, foot deformity, history of ulceration and angiopathy) is necessary for the early detection of patients at risk for developing foot disease and for preventing amputation. Better patient education about foot care and appropriate footwear are expected to prevent at least half of the amputations for diabetic foot disease (Assal et al, 1985; Edmonds et al., 1986; Schaff and Cavanagh, 1990; Barth et al., 1991; Thomson et al, 1991) .
At the time of this study, standardised diabetes patient education with the usual attention to diabetic foot care was being given at the university outpatient clinic. This individual education is repeated every two years and the feet are examined once a year or more frequently on indication.
The aim of this study was to evaluate the clinic's current screening and prevention programme by assessing the risk profile and the actual state of prevention in a sample of patients, not known to have diabetic foot complications, at the outpatient clinic. The information was intended to form a basis for further development and organisation of diabetic foot care at the hospital and rehabilitation centre.
Methods

Patients
At the diabetes outpatient clinic of the University Hospital Groningen, 55 patients who had been suffering from diabetes mellitus for at least one year, but did not have any documented foot complications, were selected at random. Exclusion criteria were: causes of neuropathy other than diabetes mellitus, other neurological diseases or peripheral nerve disorders, high dose benzodiazepine or analgesic use, cognitive or psychological problems as far as they might interfere with the test results, the presence or a history of foot ulceration and foot amputation. Five (5) patients refused to take part in this research project.
Methods
All 50 patients were examined by the same specialist (JWGM). In the same session, risk factors and preventive measures were assessed using a risk-categorisation system and the Preventive Measure Scale, respectively. Patients were not informed about the results of the tests.
Coleman 's risk categorisation
No generally accepted risk profile is available to determine a patient's risk of developing foot problems. The American Diabetes Association (ADA) recommends assessment of the four major risk factors: neuropathy, foot deformity, ulceration and angiopathy (American Diabetes Association, 2000) . The authors chose to use Coleman's risk categorisation system (Coleman, 1993) , which covers these major risk factors. Four different risk categories are used (see Table  1 ). In risk category 0 the only risk factor present is foot deformity. In category 1 neuropathy is present. In category 2 the presence of neuropathy is combined with foot deformity, while in category 3 angiopathy or an ulcer are present.
la Neuropathy
According to the recommendations of the ADA, the presence of neuropathy was determined with Seir.mes Weinstein Monofilaments (SWMF) and the Vibration Perception Threshold (VPT) (Mayfield et al, 1998) . These are semi-quantitative, reliable measurements, complementary to each other, with proven predictive value for the development of clinical problems, such as foot ulcers and the need for amputation (Goldberg and Lindblom, 1979; Bloom et al, 1984; Birke and Sims, 1986; Sosenko et al, 1990; Kumar et al, 1991; Veves et al, 1994; Young et al, 1994; Valk et al, 1997) . Both were applied 6 times to two locations on both feet. Insensitivity to the 10 gram SWMF was scored as absence of protective sensibility. The VPT was determined with a hand-held biothesiometer (Biomedical Instruments Inc., Ohio, USA) and compared to the reference values published by Young et al. (1994) . Neuropathy was defined as a disturbed VPT and/or insensitivity to the 10 gram SWMF at one location or more.
lb Foot deformity
Foot deformity was defined as comprising at least one of the following obvious deformities: claw toes, overlying toes, prominent bony parts and hallux rigidus or valgus.
lc Ulceration
Patients with ulceration or a history of ulceration were excluded from this study.
Id Angiopathy
In Coleman's system, angiopathy is defined as vascular laboratory findings indicating significant angiopathy. The authors measured ankle/brachial indexes at the arteria dorsalis pedis and arteria tibialis posterior and Table 1 . Risk profile according to Coleman (Coleman, 1993) . toe/brachial indexes at the hallux on both sides using laser-doppler flowmetry. Ankle/brachial indexes of below 0.90 and toe/brachial indexes of below 0.75 were considered abnormal (Conier, 1993) . Angiopathy was diagnosed if one or more abnormal value was observed.
The Preventive Measures Scale
According to recommendations of the American Diabetes Association, diabetic patients should be educated regarding their risk factors and appropriate management (Mayfield et al., 1998) . Assessment of a person's current knowledge and care practices should be obtained. Patients should understand the implications of the loss of protective sensation, the importance of foot monitoring on a daily basis, the proper care of the foot, including nail and skin care, and the selection of appropriate footwear. It is known that the type of evidence for the effectiveness of these specific interventions varies, ranging from evidence based (randomised controlled trials) for prescription of adequate footwear to expert or consensus opinions of the other interventions.
In literature there is no valid score available to quantify the preventive status of these patients. Therefore, a panel of medical specialists of the university hospital, all members of the Diabetic Foot working group, developed the PMS on expert and consensus opinion regarding the recommendations of the ADA, several education programmes and guidelines for shoes, and the literature (Boulton, 1992; Coleman, 1993; Edmonds and Foster, 1993; Caputo et al, 1994; Mayfield et al, 1998) .
The PMS has four sub-scales: (1) patient knowledge (7 items), (2) care practice (9 items), (3) condition of feet and shoes (10 items) and (4) prevention by health care workers (5 items). Sub-scales 1,2 and 4 are based on self-reporting, 3 is based on observation. The PMS is standardised, self-reporting questions could be answered yes or no. Observation criteria for subscale 3 were described in detail before starting the study. Adequate measures received 0 points, inadequate measures received 1 point, thus the maximum score was 31 points. The PMS is shown in Appendix 1.
Statistics
The statistical package SPSS-PC was used for all the analyses, including computation of the descriptive statistics, Spearman's Correlation Coefficient and Oneway Multiple Range Test.
Results
Characteristics of the 50 participants are shown in Table 2 . The mean age was 51.4 years (min 18, max 89 yrs), while the mean duration of DM was 14.1 years (min 1, max 36 yrs). The group consisted of 32 men and 18 women; 22 had type 1 DM and 28 had type 2 DM.
Coleman's risk categorisation
Sixty per cent (60%) of the patients had scores that placed them in risk categories 1-3. These patients were at risk. 40% scored in category 0, which means the lowest risk, because there were no risk factors (or only the presence of foot deformity without any other risk factors) ( Table 1) . Table 3 presents the mean scores on the subscales of the Preventive Measures Scale for each risk category. A large percentage of the patients were not taking any preventive measures in any of the four sub-scales. Foot-care behaviour and foot-care knowledge were inadequate. The scores for foot-care behaviour were even worse than those for foot-care knowledge.
Preventive measures
Basal preventive demands of shoes, such as fitting, presence of seamless insides and pressure distributing inlays, were absent in most patients at risk, respectively in 53% (16/30), 67% (20/30) and 70% (21/30).
No relation was found between the risk category and the preventive measures scale (Spearman's correlation coefficient .024). There were no significant differences in the scores on the preventive measures scale between the four risk categories.
Discussion
Using Coleman's risk-categorisation system, 60 per cent of the study group were found to be at serious risk of developing diabetic foot complications, despite the availability of a screening and education programme. The sample was recruited at a university hospital outpatient clinic and did not have any documented foot disorders. Foot-care knowledge and foot-care behaviour were inadequate. The scores for preventive foot-care behaviour were worse than those for foot-care knowledge; there was no relation between the sub-scale prevention and risk category. Protective measures by shoe adaptations were insufficient. This means that the screening and prevention programme, even though it follows generally prescribed procedures, is inadequate and that patients do not comply sufficiently with preventive self-care. This might be exacerbated by the fact that doctors and patients are inclined to underestimate foot care. In both doctors and patients thresholds need to be overcome in examining the feet. In doctors, time is scarce and foot inspection takes time. Many patients have visual problems, which complicate inspection, and some have cosmetic objections towards wearing orthopaedic footwear.
The study group was not fully representative of the entire population at the outpatient clinic, because of the exclusion criteria used. The study group was younger, did not have any documented foot problems, had a shorter duration of diabetes mellitus and there were relatively more male patients. The objection might be raised that the study sample was small and, because it was university-hospital-based, it was not representative. However, the percentage at risk was so high that valid conclusions can be drawn about the need for preventive care, even in this small sample. Similar risk estimates for the general population will underestimate the situation, because patients with (a history of) foot ulcers were excluded and because everyone had received standardised diabetes patient education.
Several validated tests to diagnose and evaluate neuropathy are available in different diagnostic categories, such as symptom scoring, physical examination, quantitative sensory testing, electrodiagnostic studies and autonomic function testing. According to a consensus statement one test from each of these five diagnostic categories has to be used to diagnose and evaluate neuropathy (American Diabetes Association, American Academy of Neurology, 1988) . In clinical practice, certainly at an outpatient clinic, this is not feasible for screening purposes. The ADA recently recommended the use of psychophysical somatosensory threshold tests (especially vibration perception threshold by Biothesiometry and Monofilament testing) because these tests provide the' best discrimination in the clinical setting to identify the loss of sensation (Mayfield et al, 1998) . Both recommended tests have been used in this study. However, there is still no combination of tests available with the optimal predictive value to diabetic foot ulcer. By using only these two methods still cases will be missed during screening, so the percentage at risk will even be higher than 60%.
It is questionable whether the highest risk category should be defined by the presence of angiopathy. Several studies have shown that neuropathy played a larger role in the development of ulceration and the need for amputation than angiopathy (Boulton et ah, 1986; PecaroefaZ., 1990; Thomson et al, 1991; Boulton, 1992; Boulton 1996) . This means that for the entire 60% (categories 1-3: neuropathy present) the risk is high and preventive foot care is of great importance.
Because there was no score available in the literature, the Preventive Measures Scale was developed to standardise the quantification of the preventive measures being taken by patients. Validation of the PMS was beyond the scope of this study. The PMS is not broad enough to evaluate education programmes, because information about the social system, coping, behaviour and health locus of control are lacking. However, the PMS does provide a simple, standardised instrument to assess the preventive measures being taken by patients. Three sub-scales are based on self-report. Patients might respond socially desirable, which means that the real situation of prevention is even worse than reported.
In view of the findings of this evaluation, the authors' screening and prevention programme has to be revised. Because the programme closely follows generally accepted programmes, this need for revision will hold for many institutions. In the opinion of the authors, the screening programme needs to be adapted to follow the advice of the 1998 Dutch consensus on diabetic foot disease (CBO/NDF, 1998), which means more intense examination of the presence of risk factors. Naturally, to be of any benefit, early diagnosis of patients at risk will have to be followed by preventive measures and regular check-ups. For this purpose, a multidisciplinary diabetic foot team and intensive education programmes have been started at the university hospital and rehabilitation centre. The education programme offers information and individual or group training given by a multidisciplinary rehabilitation team. The major goal of this programme is to increase the level of preventive self-care.
Physicians, podiatrists and shoe-technicians need to be aware that they will have to provide adequate footwear to an enormous number of patients at risk. Furthermore they should underpin their work, specifically the indications and effects of adaptations and their preventive value.
Using a simple risk-categorisation system combined with improved prevention strategies for patients at risk of developing diabetic foot problems, the authors are attempting to balance the presence of risk factors and the application of preventive measures. It is clear that patients, health care workers and health insurance companies will have to invest a great deal of time and money in foot care to reach the goal of the St. Vincent Declaration, i.e. a 50% reduction in major amputations. Sub-scales 1, 2 and 4 are based on self-reporting, 3 on observation. Adequate measures: 0 points, insufficient measures: 1 point, max. score 31 points. The higher the score, the greater the lack of preventive measures.
